Skip to content
Trial Eligibility
Menu

Noradrenergic Dysregulation, Sleep and Cognition in Older Adults With Insomnia

NCT06694441

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

This study investigates the relationship between the noradrenergic (NA) system, sleep quality, and cognitive function in older adults with insomnia - a population at elevated risk for Alzheimer's disease-related dementias (ADRD) - compared to age and sex matched controls with normal sleep.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Insomnia

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
55 years and older
Sex
All
Healthy volunteers
Accepted
Sponsor
Northwestern University
Last updated on ClinicalTrials.gov
March 30, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Illinois · 1

  • Northwestern University Feinberg School of Medicine, Center for Circadian and Sleep Medicine · Chicago, IL

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.